Compare Cytokinetics Inc (CYTK) vs Oxford Lane Capital Corp (OXLC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Oxford Lane Capital Corp — how do they compare? Cytokinetics Inc trades at $76.58 (market cap $10.63B), while Oxford Lane Capital Corp trades at $9.42 (market cap $909.61M). The key difference: Cytokinetics Inc is far larger — about 11.7× Oxford Lane Capital Corp's market cap, and Oxford Lane Capital Corp pays a 25.76% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | OXLC | |
|---|---|---|
Market Cap | $10.63B | $909.61M |
Sector | Technology | Financials |
52-Week High | $87.26 | $18.75 |
52-Week Low | $34.31 | $8.15 |
Enterprise Value | $10.74B | — |
Dividend Yield | — | 25.76% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Oxford Lane Capital Corp
Oxford Lane Capital Corp. is a non-diversified, closed-end management investment company. Its primary investment objective is to achieve high current income, with a secondary objective of capital appreciation. The company primarily invests in equity and junior debt tranches of collateralized loan obligations (CLOs), which are pools of corporate loans. OXLC is known for its high-yield distribution policy and provides investors with leveraged exposure to the CLO market.
Read more on OXLC →
